-
Sana Biotechnology to Present at December 2024 Investor Conferences
-
Sana Biotechnology (SANA) PT Raised to $15 at Citi, Opens Positive Catalyst Watch
-
Citi Starts Sana Biotechnology (SANA) at Buy, 'Hypoimmune Platform is a Potential Game Changer for Allogeneic Cell Therapy'
-
Sana Biotechnology to Present at September 2023 Investor Conferences

